ACTA1

Chr 1ADAR

actin alpha 1, skeletal muscle

Also known as: ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A, CMYO2B, CMYO2C

The product encoded by this gene belongs to the actin family of proteins, which are highly conserved proteins that play a role in cell motility, structure and integrity. Alpha, beta and gamma actin isoforms have been identified, with alpha actins being a major constituent of the contractile apparatus, while beta and gamma actins are involved in the regulation of cell motility. This actin is an alpha actin that is found in skeletal muscle. Mutations in this gene cause a variety of myopathies, including nemaline myopathy, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion, diseases that lead to muscle fiber defects with manifestations such as hypotonia. [provided by RefSeq, Sep 2019]

OMIMResearchGenerating clinical summary…
DNmechanismAD/ARLOEUF 1.224 OMIM phenotypes
VCEP Guidelines: Congenital MyopathiesReleased
ClinGen Panel
Clinical SummaryACTA1
🧬
Gene-Disease Validity (ClinGen)
alpha-actinopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
237 unique Pathogenic / Likely Pathogenic· 200 VUS of 627 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
1.22LOEUF
pLI 0.000
Z-score 0.93
OE 0.74 (0.461.22)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
4.53Z-score
OE missense 0.21 (0.170.26)
55 obs / 260.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.74 (0.461.22)
00.351.4
Missense OE?0.21 (0.170.26)
00.61.4
Synonymous OE?0.87
01.21.6
LoF obs/exp: 11 / 14.9Missense obs/exp: 55 / 260.9Syn Z: 1.11
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongACTA1-related nemaline myopathyOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.81top 10%
GOF
0.6051th %ile
LOF
0.3259th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNEvidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 15198992

ClinVar Variant Classifications

627 submitted variants in ClinVar

Classification Summary

Pathogenic106
Likely Pathogenic131
VUS200
Likely Benign148
Benign18
Conflicting23
106
Pathogenic
131
Likely Pathogenic
200
VUS
148
Likely Benign
18
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
88
0
0
106
Likely Pathogenic
18
111
2
0
131
VUS
4
165
24
7
200
Likely Benign
0
0
66
82
148
Benign
0
0
18
0
18
Conflicting
23
Total4036411089626

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

37 pathogenic / likely-pathogenic (of 43) ClinVar copy-number / structural variants overlap ACTA1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ACTA1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →